| Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate R Rajan, MK Sabnani, V Mavinkurve, H Shmeeda, H Mansouri, ... Journal of Controlled Release 271, 139-148, 2018 | 65 | 2018 |
| Liposome promotion of tumor growth is associated with angiogenesis and inhibition of antitumor immune responses MK Sabnani, R Rajan, B Rowland, V Mavinkurve, LM Wood, AA Gabizon, ... Nanomedicine: Nanotechnology, Biology and Medicine 11 (2), 259-262, 2015 | 57 | 2015 |
| A prospective, phase 1 trial of nivolumab, ipilimumab, and radiotherapy in patients with advanced melanoma MA Postow, SJ Knox, DA Goldman, Y Elhanati, V Mavinkurve, P Wong, ... Clinical Cancer Research 26 (13), 3193-3201, 2020 | 28 | 2020 |
| Pegylated liposomal alendronate: The impact of the drug cargo on carrier-induced immune modulation R Rajan, MK Sabnani, LM Wood, V Mavinkurve, AA Gabizon, NM La-Beck Cancer Research 76 (14_Supplement), 4008-4008, 2016 | 1 | 2016 |
| USP18 as a novel regulator of PD-1 and IFNAR1-mediated immune dysfunction (IRM11P. 629) L Wood, V Mavinkurve, G Muthukumaran, D Malo, Y Paterson The Journal of Immunology 194 (1_Supplement), 132.8-132.8, 2015 | 1 | 2015 |
| Relationship of Chromosome Arm 10q Variants to Occurrence of Multiple Primary Melanoma in the Population-Based GEM Study JA Miles, I Orlow, PA Kanetsky, L Luo, AE Cust, BK Armstrong, A Kricker, ... The Journal of investigative dermatology 139 (6), 1410, 2019 | | 2019 |
| Relationship of chromosome arm 10q variants to occurrence of multiple primary melanoma in the population-based GEM study JA Miles, I Orlow, PA Kanetsky, L Luo, AE Cust, BK Armstrong, A Kricker, ... Journal of Investigative Dermatology 39 (5), 2018 | | 2018 |
| Negative regulation of IFNAR1/2 Signaling by USP18 is required for immunity to Listeria monocytogenes R Flores, V Mavinkurve, G Muthukumaran, M Cabasal, T Nguyen, ... The Journal of Immunology 198 (1_Supplement), 151.21-151.21, 2017 | | 2017 |
